8-KExhibits & Filings

JPMORGAN CHASE & CO 8-K Report, Exhibit Filing (Jan 28, 2008)

Filed January 28, 2008For Securities:JPMJPM-PCJPM-PDJPM-PKJPM-PLJPM-PMJPM-PJAMJBVYLD

Summary

This JPMorgan Chase & Co. (JPM) 8-K filing, dated January 28, 2008, primarily serves to disclose exhibits related to various structured financial products. The key takeaway for investors is that JPM is issuing tax opinions from Davis Polk & Wardwell for a range of notes, including enhanced return notes, buffered notes, range accrual notes, principal protected notes, and reverse exchangeable notes. These notes are linked to various indices (S&P 500, EURO STOXX 50, Russell 2000, Nikkei 225) and individual stocks, with maturity dates spanning from 2008 to 2023. While this filing does not contain core financial performance data or strategic updates, it highlights JPM's ongoing activity in offering complex, derivative-based investment products. Investors interested in these types of securities should pay close attention to the underlying assets, terms, and associated risks detailed in the full exhibit documentation, which are incorporated by reference. The filing underscores the company's diverse product offerings in the structured finance market.

Key Highlights

  • 1JPMorgan Chase & Co. filed an 8-K on January 28, 2008, reporting exhibits for the event date of January 23, 2008.
  • 2The filing primarily consists of tax opinions from Davis Polk & Wardwell for several series of structured notes.
  • 3These exhibits detail tax implications for various notes including Return Enhanced Notes, Buffered Return Enhanced Notes, Range Accrual Notes, Principal Protected Dual Directional Knock-Out Notes, and Reverse Exchangeable Notes.
  • 4The underlying reference assets for these notes include major stock indices such as the S&P 500®, Dow Jones EURO STOXX 50®, Russell 2000®, and Nikkei 225®.
  • 5Some notes are linked to the common stock of specific single reference stock issuers, including Exxon Mobil Corporation.
  • 6Maturity dates for these notes range from April 2008 to February 2023, indicating a diverse range of financial instruments offered by the company.
  • 7This filing does not contain specific financial results or operational updates, but rather focuses on the legal and tax aspects of newly issued financial products.

Frequently Asked Questions